Selected research
Market Structure
Global Companion Animal Anti-infectives Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Companion Animal Anti-infectives market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Companion Animal Anti-infectives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Companion Animal Anti-infectives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Companion Animal Anti-infectives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Companion Animal Anti-infectives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Companion Animal Anti-infectives include Bimeda Animal Health, Boehringer Ingelheim, Ceva Sante Animale, Chanelle, Elanco, Vetoquinol, Virbac, Bayer and Merck, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Companion Animal Anti-infectives market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Companion Animal Anti-infectives and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Companion Animal Anti-infectives sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Companion Animal Anti-infectives market size, projected growth trends, production technologies, key applications, and end-use industries.
Companion Animal Anti-infectives Segment by Company
Bimeda Animal Health
Boehringer Ingelheim
Ceva Sante Animale
Chanelle
Elanco
Vetoquinol
Virbac
Bayer
Merck
Zoetis
Companion Animal Anti-infectives Segment by Type
Injection
Unguent
Companion Animal Anti-infectives Segment by Application
Dogs
Cats
Other
Companion Animal Anti-infectives Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Companion Animal Anti-infectives market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Companion Animal Anti-infectives and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Companion Animal Anti-infectives.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Companion Animal Anti-infectives market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Companion Animal Anti-infectives manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Companion Animal Anti-infectives in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Companion Animal Anti-infectives in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Injection
- Unguent
Applications
- Dogs
- Cats
- Other
Companies covered
- Bimeda Animal Health
- Boehringer Ingelheim
- Ceva Sante Animale
- Chanelle
- Elanco
- Vetoquinol
- Virbac
- Bayer
- Merck
- Zoetis
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Companion Animal Anti-infectives Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Companion Animal Anti-infectives Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Companion Animal Anti-infectives Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Companion Animal Anti-infectives Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Companion Animal Anti-infectives Market Dynamics
- 2.1 Companion Animal Anti-infectives Industry Trends
- 2.2 Companion Animal Anti-infectives Industry Drivers
- 2.3 Companion Animal Anti-infectives Industry Opportunities and Challenges
- 2.4 Companion Animal Anti-infectives Industry Restraints
3 Companion Animal Anti-infectives Market by Manufacturers
- 3.1 Global Companion Animal Anti-infectives Revenue by Manufacturers (2021-2026)
- 3.2 Global Companion Animal Anti-infectives Sales by Manufacturers (2021-2026)
- 3.3 Global Companion Animal Anti-infectives Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Companion Animal Anti-infectives Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Companion Animal Anti-infectives Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Companion Animal Anti-infectives Manufacturers, Product Type & Application
- 3.7 Global Companion Animal Anti-infectives Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Companion Animal Anti-infectives Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Companion Animal Anti-infectives Players Market Share by Revenue in 2025
- 3.8.3 2025 Companion Animal Anti-infectives Tier 1, Tier 2, and Tier 3
4 Companion Animal Anti-infectives Market by Type
- 4.1 Companion Animal Anti-infectives Type Introduction
- 4.1.1 Injection
- 4.1.2 Unguent
- 4.2 Global Companion Animal Anti-infectives Sales by Type
- 4.2.1 Global Companion Animal Anti-infectives Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Companion Animal Anti-infectives Sales by Type (2021-2032)
- 4.2.3 Global Companion Animal Anti-infectives Sales Market Share by Type (2021-2032)
- 4.3 Global Companion Animal Anti-infectives Revenue by Type
- 4.3.1 Global Companion Animal Anti-infectives Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Companion Animal Anti-infectives Revenue by Type (2021-2032)
- 4.3.3 Global Companion Animal Anti-infectives Revenue Market Share by Type (2021-2032)
5 Companion Animal Anti-infectives Market by Application
- 5.1 Companion Animal Anti-infectives Application Introduction
- 5.1.1 Dogs
- 5.1.2 Cats
- 5.1.3 Other
- 5.2 Global Companion Animal Anti-infectives Sales by Application
- 5.2.1 Global Companion Animal Anti-infectives Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Companion Animal Anti-infectives Sales by Application (2021-2032)
- 5.2.3 Global Companion Animal Anti-infectives Sales Market Share by Application (2021-2032)
- 5.3 Global Companion Animal Anti-infectives Revenue by Application
- 5.3.1 Global Companion Animal Anti-infectives Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Companion Animal Anti-infectives Revenue by Application (2021-2032)
- 5.3.3 Global Companion Animal Anti-infectives Revenue Market Share by Application (2021-2032)
6 Global Companion Animal Anti-infectives Sales by Region
- 6.1 Global Companion Animal Anti-infectives Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Companion Animal Anti-infectives Sales by Region (2021-2032)
- 6.2.1 Global Companion Animal Anti-infectives Sales by Region (2021-2026)
- 6.2.2 Global Companion Animal Anti-infectives Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Companion Animal Anti-infectives Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Companion Animal Anti-infectives Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Companion Animal Anti-infectives Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Companion Animal Anti-infectives Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Companion Animal Anti-infectives Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Companion Animal Anti-infectives Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Companion Animal Anti-infectives Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Companion Animal Anti-infectives Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Companion Animal Anti-infectives Revenue by Region
- 7.1 Global Companion Animal Anti-infectives Revenue by Region
- 7.1.1 Global Companion Animal Anti-infectives Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Companion Animal Anti-infectives Revenue by Region (2021-2026)
- 7.1.3 Global Companion Animal Anti-infectives Revenue by Region (2027-2032)
- 7.1.4 Global Companion Animal Anti-infectives Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Companion Animal Anti-infectives Revenue (2021-2032)
- 7.2.2 North America Companion Animal Anti-infectives Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Companion Animal Anti-infectives Revenue (2021-2032)
- 7.3.2 Europe Companion Animal Anti-infectives Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Companion Animal Anti-infectives Revenue (2021-2032)
- 7.4.2 Asia-Pacific Companion Animal Anti-infectives Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Companion Animal Anti-infectives Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Companion Animal Anti-infectives Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Bimeda Animal Health
- 8.1.1 Bimeda Animal Health Company Information
- 8.1.2 Bimeda Animal Health Business Overview
- 8.1.3 Bimeda Animal Health Companion Animal Anti-infectives Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Bimeda Animal Health Companion Animal Anti-infectives Product Portfolio
- 8.1.5 Bimeda Animal Health Recent Developments
- 8.2 Boehringer Ingelheim
- 8.2.1 Boehringer Ingelheim Company Information
- 8.2.2 Boehringer Ingelheim Business Overview
- 8.2.3 Boehringer Ingelheim Companion Animal Anti-infectives Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Boehringer Ingelheim Companion Animal Anti-infectives Product Portfolio
- 8.2.5 Boehringer Ingelheim Recent Developments
- 8.3 Ceva Sante Animale
- 8.3.1 Ceva Sante Animale Company Information
- 8.3.2 Ceva Sante Animale Business Overview
- 8.3.3 Ceva Sante Animale Companion Animal Anti-infectives Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Ceva Sante Animale Companion Animal Anti-infectives Product Portfolio
- 8.3.5 Ceva Sante Animale Recent Developments
- 8.4 Chanelle
- 8.4.1 Chanelle Company Information
- 8.4.2 Chanelle Business Overview
- 8.4.3 Chanelle Companion Animal Anti-infectives Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Chanelle Companion Animal Anti-infectives Product Portfolio
- 8.4.5 Chanelle Recent Developments
- 8.5 Elanco
- 8.5.1 Elanco Company Information
- 8.5.2 Elanco Business Overview
- 8.5.3 Elanco Companion Animal Anti-infectives Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Elanco Companion Animal Anti-infectives Product Portfolio
- 8.5.5 Elanco Recent Developments
- 8.6 Vetoquinol
- 8.6.1 Vetoquinol Company Information
- 8.6.2 Vetoquinol Business Overview
- 8.6.3 Vetoquinol Companion Animal Anti-infectives Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Vetoquinol Companion Animal Anti-infectives Product Portfolio
- 8.6.5 Vetoquinol Recent Developments
- 8.7 Virbac
- 8.7.1 Virbac Company Information
- 8.7.2 Virbac Business Overview
- 8.7.3 Virbac Companion Animal Anti-infectives Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Virbac Companion Animal Anti-infectives Product Portfolio
- 8.7.5 Virbac Recent Developments
- 8.8 Bayer
- 8.8.1 Bayer Company Information
- 8.8.2 Bayer Business Overview
- 8.8.3 Bayer Companion Animal Anti-infectives Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Bayer Companion Animal Anti-infectives Product Portfolio
- 8.8.5 Bayer Recent Developments
- 8.9 Merck
- 8.9.1 Merck Company Information
- 8.9.2 Merck Business Overview
- 8.9.3 Merck Companion Animal Anti-infectives Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Merck Companion Animal Anti-infectives Product Portfolio
- 8.9.5 Merck Recent Developments
- 8.10 Zoetis
- 8.10.1 Zoetis Company Information
- 8.10.2 Zoetis Business Overview
- 8.10.3 Zoetis Companion Animal Anti-infectives Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Zoetis Companion Animal Anti-infectives Product Portfolio
- 8.10.5 Zoetis Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Companion Animal Anti-infectives Value Chain Analysis
- 9.1.1 Companion Animal Anti-infectives Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Companion Animal Anti-infectives Production Mode & Process
- 9.2 Companion Animal Anti-infectives Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Companion Animal Anti-infectives Distributors
- 9.2.3 Companion Animal Anti-infectives Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst